Chen, Y., Yang, L., Huang, Y., Zhu, T., Zhang, L., Cheng, M., Wu, C., Li, P., Liang, M., Zhang, X., Peng, H., Wang, K.

Background
Neoadjuvant immunotherapy combined with chemotherapy (Chemo-IM) is associated with significantly improved pathological complete response (pCR) rates and long-term survival outcomes in patient with early-stage triple-negative breast cancer (…